SCHEMBL21131815

SCHEMBL21131815

FC(F)(F)c1ccc(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)cc1-c1cc(-n2c3ccccc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)ccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KIF11 P52732 1/20 0.36
NR3C1 P04150 1/20 0.35
PGR P06401 1/20 0.35
PTGES O14684 2/20 0.35
JAK3 P52333 4/20 0.34
JAK1 P23458 3/20 0.34
JAK2 O60674 2/20 0.34
AR P10275 3/20 0.34
TYK2 P29597 1/20 0.33
NPY5R Q15761 1/20 0.33
TRPA1 O75762 1/20 0.33
PPARG P37231 2/20 0.32
PPARA Q07869 2/20 0.32
HSD11B1 P28845 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131814 1.00 KDM4E (0.43) KDM4EATML3MBTL1KIF11NR3C1
SCHEMBL21131778 0.91 KIF11 (0.46) KDM4EATML3MBTL1KIF11PGR
SCHEMBL21132054 0.91 KDM4E (0.43) KDM4EATML3MBTL1KIF11NR3C1
SCHEMBL21132055 0.91 KDM4E (0.43) KDM4EATML3MBTL1KIF11NR3C1
SCHEMBL21131812 0.90 KDM4E (0.38) KDM4EATML3MBTL1KIF11PGR
SCHEMBL21131610 0.89 KDM4E (0.40) KDM4EATML3MBTL1KIF11NR3C1
SCHEMBL21131611 0.89 KIF11 (0.40) KDM4EATML3MBTL1KIF11PGR
SCHEMBL21132059 0.87 AR (0.38) KDM4EATML3MBTL1KIF11AR
SCHEMBL21132068 0.87 MAPT (0.52) KDM4EATML3MBTL1PPARG
SCHEMBL21132061 0.85 KIF11 (0.52) KDM4EATML3MBTL1KIF11PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11380849-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2022-07-05 US disclosed
EP-3478657-B1 DICARBAZOLBIPHENYLDERIVATIVES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-04-21 EP disclosed
US-20190198778-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11380849-B2 Organic molecules for use in optoelectronic devices OR10J3, NOX3, ORC3 KDM4E 2007/4885ATM 3357/4885L3MBTL1 2730/4885
US-20190198778-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES ORC3, OR10J3, NOX3 KDM4E 1400/4885ATM 3830/4885L3MBTL1 3071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.